Stock listing
Orexo Ab
Selected listing: C5G · FWB · EUR · DE
Orexo Ab (Frankfurt:C5G), Health Technology. Latest release Sep 1, 2026: Orexo reaches non-binding agreement in principle to settle investigation by US…
- Ticker
- Frankfurt:C5G
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Frankfurt
- Currency
- EUR
About Orexo Ab
The company focuses on developing and commercializing pharmaceutical products. Orexo aims to address unmet medical needs through innovative solutions in the healthcare sector.
Latest news from Orexo Ab
Orexo reaches non-binding agreement in principle to settle investigation by US Department of Justice
August 31, 2026
Orexo appoints Raheleh Nassaji as SVP Business Development, strengthening its focus on new partnerships
June 9, 2026
Orexo announces positive outcome from an in-vivo study of OX390
May 19, 2026
Orexo : Earnings Call Q1 2026 (engelska)
April 28, 2026
Orexo : Earnings Call Q1 2026
April 28, 2026
Events
Research Orexo Ab
Alternate listings
ORX:OMXSTO
SE · SEK
Alternate listing for Orexo Ab; the primary context on this page is C5G:FWB.
A0HG6G:LSX
DE · EUR
Alternate listing for Orexo Ab; the primary context on this page is C5G:FWB.
0H19:LSIN
GB · SEK
Alternate listing for Orexo Ab; the primary context on this page is C5G:FWB.
A0HG6G:LS
DE · EUR
Alternate listing for Orexo Ab; the primary context on this page is C5G:FWB.
ORXOF:OTC
US · USD
Alternate listing for Orexo Ab; the primary context on this page is C5G:FWB.
ORXOY:OTC
US · USD
Alternate listing for Orexo Ab; the primary context on this page is C5G:FWB.
ORXS:AQUISUK
GB · SEK
Alternate listing for Orexo Ab; the primary context on this page is C5G:FWB.
ORXS:AQUISEU
GB · SEK
Alternate listing for Orexo Ab; the primary context on this page is C5G:FWB.
C5G:SWB
DE · EUR
Alternate listing for Orexo Ab; the primary context on this page is C5G:FWB.
ORXS:TURQUOISE
GB · SEK
Alternate listing for Orexo Ab; the primary context on this page is C5G:FWB.